93 related articles for article (PubMed ID: 35981285)
1. Unveiling metabotype clustering in resveratrol, daidzein, and ellagic acid metabolism: Prevalence, associated gut microbiomes, and their distinctive microbial networks.
Eduardo Iglesias-Aguirre C; Romo-Vaquero M; Victoria Selma M; Carlos Espín J
Food Res Int; 2023 Nov; 173(Pt 2):113470. PubMed ID: 37803793
[TBL] [Abstract][Full Text] [Related]
2. (Poly)phenol-related gut metabotypes and human health: an update.
Hu J; Mesnage R; Tuohy K; Heiss C; Rodriguez-Mateos A
Food Funct; 2024 Mar; 15(6):2814-2835. PubMed ID: 38414364
[TBL] [Abstract][Full Text] [Related]
3. Factors driving the inter-individual variability in the metabolism and bioavailability of (poly)phenolic metabolites: A systematic review of human studies.
Favari C; Rinaldi de Alvarenga JF; Sánchez-Martínez L; Tosi N; Mignogna C; Cremonini E; Manach C; Bresciani L; Del Rio D; Mena P
Redox Biol; 2024 May; 71():103095. PubMed ID: 38428187
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota.
Godos J; Romano GL; Gozzo L; Laudani S; Paladino N; Dominguez Azpíroz I; Martínez López NM; Giampieri F; Quiles JL; Battino M; Galvano F; Drago F; Grosso G
Front Pharmacol; 2024; 15():1368949. PubMed ID: 38562461
[TBL] [Abstract][Full Text] [Related]
5. (Poly)phenolic compounds and gut microbiome: new opportunities for personalized nutrition.
Narduzzi L; Agulló V; Favari C; Tosi N; Mignogna C; Crozier A; Rio DD; Mena P
Microbiome Res Rep; 2022; 1(3):16. PubMed ID: 38046361
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities.
Brown K; Theofanous D; Britton RG; Aburido G; Pepper C; Sri Undru S; Howells L
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255828
[TBL] [Abstract][Full Text] [Related]
7. Cell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols.
Sorrenti V; Buriani A; Fortinguerra S; Davinelli S; Scapagnini G; Cassidy A; De Vivo I
Adv Nutr; 2023 Sep; 14(5):1111-1130. PubMed ID: 37271484
[TBL] [Abstract][Full Text] [Related]
8. Accounting Gut Microbiota as the Mediator of Beneficial Effects of Dietary (Poly)phenols on Skeletal Muscle in Aging.
Ticinesi A; Nouvenne A; Cerundolo N; Parise A; Meschi T
Nutrients; 2023 May; 15(10):. PubMed ID: 37242251
[TBL] [Abstract][Full Text] [Related]
9. Microbial Metabolism of the Soy Isoflavones Daidzein and Genistein in Postmenopausal Women: Human Intervention Study Reveals New Metabotypes.
Soukup ST; Engelbert AK; Watzl B; Bub A; Kulling SE
Nutrients; 2023 May; 15(10):. PubMed ID: 37242235
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications.
Akpoveso OP; Ubah EE; Obasanmi G
Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36670985
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Characterization of a Novel Resveratrol Xylobioside Obtained Using a Mutagenic Variant of a GH10 Endoxylanase.
Pozo-Rodríguez A; Méndez-Líter JA; García-Villalba R; Beltrán D; Calviño E; Santana AG; de Eugenio LI; Cañada FJ; Prieto A; Barriuso J; Tomás-Barberán FA; Martínez MJ
Antioxidants (Basel); 2022 Dec; 12(1):. PubMed ID: 36670947
[TBL] [Abstract][Full Text] [Related]
12. Exosome-Containing Extracellular Vesicles Contribute to the Transport of Resveratrol Metabolites in the Bloodstream: A Human Pharmacokinetic Study.
Iglesias-Aguirre CE; Ávila-Gálvez MÁ; López de Las Hazas MC; Dávalos A; Espín JC
Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079893
[TBL] [Abstract][Full Text] [Related]
13. Lunularin Producers versus Non-producers: Novel Human Metabotypes Associated with the Metabolism of Resveratrol by the Gut Microbiota.
Iglesias-Aguirre CE; Vallejo F; Beltrán D; Aguilar-Aguilar E; Puigcerver J; Alajarín M; Berná J; Selma MV; Espín JC
J Agric Food Chem; 2022 Aug; 70(34):10521-10531. PubMed ID: 35981285
[TBL] [Abstract][Full Text] [Related]
14. Main Determinants Affecting the Antiproliferative Activity of Stilbenes and Their Gut Microbiota Metabolites in Colon Cancer Cells: A Structure-Activity Relationship Study.
González-Sarrías A; Espín-Aguilar JC; Romero-Reyes S; Puigcerver J; Alajarín M; Berná J; Selma MV; Espín JC
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499424
[No Abstract] [Full Text] [Related]
15. 4-Hydroxydibenzyl: a novel metabolite from the human gut microbiota after consuming resveratrol.
Iglesias-Aguirre CE; Vallejo F; Beltrán D; Berná J; Puigcerver J; Alajarín M; Selma MV; Espín JC
Food Funct; 2022 Jul; 13(14):7487-7493. PubMed ID: 35762857
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota.
Bode LM; Bunzel D; Huch M; Cho GS; Ruhland D; Bunzel M; Bub A; Franz CM; Kulling SE
Am J Clin Nutr; 2013 Feb; 97(2):295-309. PubMed ID: 23283496
[TBL] [Abstract][Full Text] [Related]
17. Where to Look into the Puzzle of Polyphenols and Health? The Postbiotics and Gut Microbiota Associated with Human Metabotypes.
Cortés-Martín A; Selma MV; Tomás-Barberán FA; González-Sarrías A; Espín JC
Mol Nutr Food Res; 2020 May; 64(9):e1900952. PubMed ID: 32196920
[TBL] [Abstract][Full Text] [Related]
18. The gut microbiota: A key factor in the therapeutic effects of (poly)phenols.
Espín JC; González-Sarrías A; Tomás-Barberán FA
Biochem Pharmacol; 2017 Sep; 139():82-93. PubMed ID: 28483461
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
